Ricinelaidic acid
Ricinelaidic acid, a 12-hydroxy fatty acid, is a leukotriene B4 (LTB4) receptor antagonist with the Ki of 2 μM in porcine neutrophil membranes. Ricinelaidic acid inhibits chemotaxis and calcium flux induced by LTB4 in isolated human neutrophils (IC50=10 and 7 μM, respectively) . Ricinelaidic acid inhibits bronchoconstriction induced by LTB4 in rats[1].
Product Specifications
CAS Number
540-12-5
UNSPSC
12352211
Hazard Statement
H225-H319
Target
Calcium Channel; Endogenous Metabolite; Leukotriene Receptor
Related Pathways
GPCR/G Protein; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Smiles
OC(CCCCCCC/C=C/C[C@H](O)CCCCCC)=O
Molecular Formula
C18H34O3
Molecular Weight
298.46
Precautions
P210-P233-P240-P241-P242-P243-P264-P280-P303+P361+P353-P305+P351+P338-P370+P378-P403+P235-P501
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Cytokeratin 19 (A53-B/A2.26), CF594 conjugate, 0.1mg/mL
